Research News and Research

RSS
Transitioning Infrared Imaging into Clinical Use

Transitioning Infrared Imaging into Clinical Use

Georgia State and Morehouse partner to reduce diabetes, cardiovascular disease rates in southwest Atlanta

Georgia State and Morehouse partner to reduce diabetes, cardiovascular disease rates in southwest Atlanta

Pazopanib improves survival in soft tissue sarcoma patients without impairment of health-related quality of life

Pazopanib improves survival in soft tissue sarcoma patients without impairment of health-related quality of life

Sialic acid attached to brain cells may affect brain structure, cause neurological problems

Sialic acid attached to brain cells may affect brain structure, cause neurological problems

Breakthrough discovery could help young girls suffering from rare form of epilepsy

Breakthrough discovery could help young girls suffering from rare form of epilepsy

Common arthritis drug could help to treat patients with blood cancers

Common arthritis drug could help to treat patients with blood cancers

Celtaxsys receives FDA clearance to begin acebilustat Phase 2 trial in adult CF patients in the US

Celtaxsys receives FDA clearance to begin acebilustat Phase 2 trial in adult CF patients in the US

INTEGRA announces $10,000 contribution to Dana-Farber Cancer Institute

INTEGRA announces $10,000 contribution to Dana-Farber Cancer Institute

Healthcare innovations pioneered in the East Midlands to benefit millions of people throughout England

Healthcare innovations pioneered in the East Midlands to benefit millions of people throughout England

Leica DM2500 LED Microscope for clinical laboratories and research applications launched by Leica Microsystems

Leica DM2500 LED Microscope for clinical laboratories and research applications launched by Leica Microsystems

Socioeconomic conditions in early life influence adult's physical activity, shows research

Socioeconomic conditions in early life influence adult's physical activity, shows research

Allergan enters into agreement to acquire Oculeve

Allergan enters into agreement to acquire Oculeve

ImmunoCellular, Novella partner to conduct ICT-107 phase 3 registration trial in patients with glioblastoma

ImmunoCellular, Novella partner to conduct ICT-107 phase 3 registration trial in patients with glioblastoma

Parents' views on safety and benefits of vaccines have shifted, finds new poll

Parents' views on safety and benefits of vaccines have shifted, finds new poll

28th ECNP Congress of the European College of Neuropsychopharmacology to take place in Amsterdam

28th ECNP Congress of the European College of Neuropsychopharmacology to take place in Amsterdam

Researchers unravel mechanisms that enable accumulation of tumour promoting protease in stressed cancer cells

Researchers unravel mechanisms that enable accumulation of tumour promoting protease in stressed cancer cells

UTHealth School of Public Health working to improve health of Hispanics living along Texas-Mexico border

UTHealth School of Public Health working to improve health of Hispanics living along Texas-Mexico border

Research Instruments receives European patent for RI Witness system

Research Instruments receives European patent for RI Witness system

Nihon University announces first international symposium on Medical-Engineering Collaboration

Nihon University announces first international symposium on Medical-Engineering Collaboration

Brunel University student produces animated short film on understanding visually impaired people

Brunel University student produces animated short film on understanding visually impaired people

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.